Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.35 |
| ▸ | CTSV | O60911 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | CTSC | P53634 | 1/20 | 0.34 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP13 | P45452 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13013398 | 1.00 | TMEM97 (0.37) | TMEM97SIGMAR1HPSETP53OPRM1 | |
| SCHEMBL10703049 | 1.00 | TMEM97 (0.37) | TMEM97SIGMAR1HPSETP53OPRM1 | |
| SCHEMBL6853632 | 0.92 | TMEM97 (0.36) | TMEM97SIGMAR1HPSETP53OPRM1 | |
| SCHEMBL13868581 | 0.90 | HPSE (0.39) | TMEM97SIGMAR1HPSETP53OPRM1 | |
| SCHEMBL16950173 | 0.90 | TMEM97 (0.38) | TMEM97SIGMAR1HPSETP53OPRM1 | |
| SCHEMBL10957780 | 0.90 | OPRM1 (0.37) | OPRM1OPRD1MAOBPOLBMAOA | |
| SCHEMBL6855778 | 0.89 | HPSE (0.34) | TMEM97SIGMAR1HPSETP53OPRM1 | |
| SCHEMBL17068337 | 0.89 | TMEM97 (0.36) | TMEM97SIGMAR1HPSETP53OPRM1 | |
| SCHEMBL17068318 | 0.89 | TMEM97 (0.36) | TMEM97SIGMAR1HPSETP53OPRM1 | |
| SCHEMBL886854 | 0.88 | TMEM97 (0.38) | TMEM97SIGMAR1HPSETP53OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4211123-B1 | ANTITUMORAL ASCORBIC ACID ESTERS | SUIGENERIS FARM S L (ES) | 2024-11-06 | — | — | EP | disclosed |
| CN-116724028-A | Anti-tumor ascorbate | 独特药妆公司 | 2023-09-08 | — | — | CN | disclosed |
| US-20230278974-A1 | ANTITUMORAL ASCORBIC ACID ESTERS | SUIGENERIS FARMACOSMETICS, S.L. (ES) | 2023-09-07 | — | — | US | disclosed |
| US-20230278974-A1 | ANTITUMORAL ASCORBIC ACID ESTERS | SUIGENERIS FARMACOSMETICS, S.L. (ES) | 2023-09-07 | — | — | US | disclosed |
| EP-4211123-A1 | ANTITUMORAL ASCORBIC ACID ESTERS | Suigeneris Farmacosmetics, S.L. (ES) | 2023-07-19 | — | — | EP | disclosed |
| EP-3967684-A1 | ANTITUMORAL ASCORBIC ACID ESTERS | Suigeneris Farmacosmetics, S.L. (ES) | 2022-03-16 | — | — | EP | disclosed |
| US-20150250169-A1 | ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT | NIPPON SODA CO., LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
| EP-2902387-A1 | ASCORBIC ACID-RELATED COMPOUND AND ANTI-PLANT-VIRUS AGENT | Nippon Soda Co., Ltd. (JP) | 2015-08-05 | — | — | EP | disclosed |
| WO-2013021105-A2 | NOVEL DERIVATIVES OF FURANONES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | ASCORBIX SARL (FR) | 2013-02-14 | — | — | WO | disclosed |
| US-5750516-A | ANTIOXIDANT; ANTIISCHEMIC AGENT | SENJU PHARMACEUTICAL CO., LTD. (JP) | 1998-05-12 | — | — | US | disclosed |
| EP-0768314-A1 | Ascorbic acid tocopheryl phosphate diesters | Senju Pharmaceutical Co., Ltd. (JP) | 1997-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230278974-A1 | ANTITUMORAL ASCORBIC ACID ESTERS | RNASE1, AKR1C3, CYP27A1 | TMEM97 4472/4885SIGMAR1 2664/4885HPSE 3454/4885 |
| US-20150250169-A1 | ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT | CBR3, OSR1, OXSR1 | TMEM97 3815/4885SIGMAR1 470/4885HPSE 4063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.